What is the appropriate prazosin dosing regimen for treating nightmares?

Prazosin Dosing for Nightmares

Start prazosin at 1 mg at bedtime and titrate gradually to a target range of 10–15 mg nightly, with men typically requiring higher doses (15.6 mg) than women (7.0 mg), and avoid concurrent SSRI use whenever possible as it markedly reduces efficacy. 1, 2

Initial Dosing

• Always begin with 1 mg at bedtime to minimize the risk of syncope and orthostatic hypotension, which occurs in approximately 1% of patients started at 2 mg or higher 2
• The FDA label explicitly states that 2 mg and 5 mg capsules are not indicated for initial therapy 2
• First-dose syncope typically occurs within 30–90 minutes of administration and is self-limiting 2

Titration Strategy

• Increase the dose gradually over several weeks based on nightmare frequency and tolerability 1
• Target therapeutic range: 10–15 mg at bedtime for most patients, though the effective range spans 1–20 mg daily 1
• Some patients may benefit from doses up to 20 mg, though higher doses rarely increase efficacy 2
• Gender-specific dosing is critical: men typically require ~15.6 mg while women require ~7.0 mg on average 1, 3

Split Dosing Considerations

• For patients with daytime flashbacks or breakthrough symptoms, consider adding a midmorning dose of 4–5 mg for men or 2 mg for women 3
• Split dosing (bedtime plus midmorning) was used successfully in active-duty soldiers, with mean achieved doses of 15.6 mg at bedtime + 4.0 mg midmorning for men 3
• Given prazosin's 2–3 hour half-life, twice-daily or even three-times-daily dosing may prevent breakthrough symptoms between doses 4

Critical Drug Interaction: SSRIs

• Concurrent SSRI therapy dramatically reduces prazosin efficacy and should be avoided or modified when possible 1
• In active-duty soldiers, total PTSD symptom reduction was 30.1 points without SSRIs versus only 9.6 points with concurrent SSRI use 1
• The largest negative trial (304 patients) showed no benefit, likely because 78% were on concurrent antidepressants 1
• If the patient is already on an SSRI, discuss modifying antidepressant therapy before initiating prazosin 1

Monitoring Requirements

• Measure blood pressure at each dose increase to assess for orthostatic hypotension 1
• Assess nightmare frequency at least weekly during titration 1
• Monitor for dizziness and lightheadedness, the most common adverse effects, which typically resolve without discontinuation 1
• No falls or syncopal episodes were recorded in major RCTs, and blood pressure remains largely unchanged in most patients 1

Expected Timeline

• Clinical improvement typically emerges between 8 and 15 weeks after initiation 1, 3
• Some patients experience more rapid response within weeks, particularly for nightmare frequency 5
• Nightmare frequency decreased from 4 to 2 times per week on average in veteran populations 6

Patient Selection

• Prazosin is first-line pharmacologic therapy for PTSD-related nightmares according to the American Academy of Sleep Medicine 1
• Best candidates are patients not on SSRIs or willing to modify antidepressant therapy 1
• Prazosin is effective in both military veterans and civilian populations with PTSD 1
• Evidence supports use in pediatric populations (ages 13–18) at lower doses of 1–4 mg daily (0.02–0.3 mg/kg) 7, 8

Common Pitfalls

• Do not start at doses >1 mg due to syncope risk 2
• Do not ignore concurrent SSRI use—this is the primary reason for treatment failure 1
• Do not discontinue abruptly—taper gradually as sudden cessation leads to return of nightmares to baseline 1
• Do not assume lack of response means treatment failure—ensure adequate dosing (10–15 mg) and sufficient duration (8–15 weeks) before declaring inefficacy 1

Adjunctive Considerations

• Combine with trauma-focused psychotherapy for optimal outcomes, as 79% of successfully treated patients received concurrent cognitive behavioral therapy 7
• Benzodiazepine co-administration may enhance prazosin efficacy for insomnia and overall PTSD severity, though this requires further study 9
• Prazosin improves not only nightmares but also sleep quality, global function, and hyperarousal symptoms 3

Safety Profile

• Transient dizziness and mild orthostatic hypotension are most common, usually resolving without discontinuation 1
• Rare but serious: priapism has been reported with alpha-1 blockers; advise patients to seek immediate care for erections lasting >4 hours 2
• Additive hypotensive effects occur with PDE-5 inhibitors; initiate PDE-5 inhibitors at lowest dose if needed 2
• When adding other antihypertensives, reduce prazosin to 1–2 mg three times daily and retitrate 2